Oral contraceptive use and bone mineral density in premenopausal women: cross-sectional, population-based data from the Canadian Multicentre Osteoporosis Study
Claudie Berger, David A Hanley, Stuart A Jackson, Jonathan D Adachi, Joseph L., Timothy M Murray, Jerilynn C Prior, Y M Vigna, L Blondeau, Nancy Kreiger, Alan Tenenhouse
Positive and negative effects on bone mineral density (BMD) have been described as a result of the premenopausal use of oral contraceptives (OCs); increased fracture rates have also been reported. This study assessed the relation between OC use and BMD in a population-based, 9-centre, national sample of women aged 25-45 years.
Methods
Premenopausal women who had been enrolled in the Canadian Multicentre Osteoporosis Study were classified as having ever been OC users (> or = 3 months) or as having never been OC users (0 to < 3 months). Data were obtained through extensive questionnaires and measuring of participants' weight, height and the BMD of lumbar vertebrae and the proximal femur.
Results
Of the sample of 524 women, whose mean age was 36.3 (standard deviation [SD] 5.9) years, 454 had used OCs; their mean age when they started using OCs was 19.8 (SD 3.5) years and the mean duration of use was 6.8 (SD 4.8) years. Women who had ever and those who had never used OCs showed no differences in age, age at menarche, parity, current calcium intake, exercise, body mass index (BMI), education, past irregular cycles or amenorrhea. OC users reported more alcohol and cigarette use and more use of medications to create regular cycles. Mean BMD values (adjusted for age, BMI and height) were 0.02-0.04 g/cm2 (that is, 2.3%-3.7%) lower in OC users, and were significantly lower in the spine and trochanter. The BMD of the spine in OC users was 1.03 (SD 0.12) g/cm2 versus 1.07 (SD 0.12) g/cm2 (95% confidence interval [CI] of difference -0.07 to -0.001) in those who had never used OCs. BMD was neither related to the duration of OC use nor to gynecological age at first use. Current and past users had similar BMD values.
Interpretation
National, population-based data show lower BMD values for the trochanter and spine in premenopausal women who have used OCs compared with those who have never used OCs.
oral contraceptive use bone mineral density premenopausal women, Prior JC oral contraceptives bone density population study, Canadian Multicentre Osteoporosis Study premenopausal OC users, oral contraceptive lower spine trochanter BMD, hormonal contraception bone health young women cross-sectional, OC use duration bone mineral density relationship, population-based study oral contraceptive skeletal effects, premenopausal women BMD lumbar spine oral contraceptive exposure, oral contraceptive negative effect bone density CaMos, contraceptive pill osteoporosis risk premenopausal cross-sectional
Cite this article
Prior, J. C., Kirkland, S. A., Joseph, L., Kreiger, N., Murray, T. M., Hanley, D. A., Adachi, J. D., Vigna, Y. M., Berger, C., Blondeau, L., Jackson, S. A., & Tenenhouse, A. (2001). Oral contraceptive use and bone mineral density in premenopausal women: cross-sectional, population-based data from the Canadian Multicentre Osteoporosis Study. *CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne*, *165*(8), 1023-1029.
Prior JC, Kirkland SA, Joseph L, Kreiger N, Murray TM, Hanley DA, et al. Oral contraceptive use and bone mineral density in premenopausal women: cross-sectional, population-based data from the Canadian Multicentre Osteoporosis Study. CMAJ. 2001;165(8):1023-1029.
Prior, J. C., et al. "Oral contraceptive use and bone mineral density in premenopausal women: cross-sectional, population-based data from the Canadian Multicentre Osteoporosis Study." *CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne*, vol. 165, no. 8, 2001, pp. 1023-1029.
Gronich N et al., 2011
Open Access
CMAJ : Canadian Medical Association Journal = Journal De l'Association Medicale Canadienne
Background: Combined oral contraceptives are a common method of contraception, but they carry a risk of venous and arterial thrombosis. We assessed whether use of drospirenone was associated with an i...
Collier R, 2011
Open Access
CMAJ : Canadian Medical Association Journal = Journal De l'Association Medicale Canadienne
Amy Kuebelbeck was 25 weeks into her pregnancy when she received the terrible news. Her fetus had been diagnosed with an incurable heart defect. If she carried through with her pregnancy, her baby's l...
Berger C et al., 2008
Open Access
CMAJ : Canadian Medical Association Journal = Journal De l'Association Medicale Canadienne
Background: Measurement of bone mineral density is the most common method of diagnosing and assessing osteoporosis. We sought to estimate the average rate of change in bone mineral density as a functi...
WM Hopman et al., 2000CMAJ : Canadian Medical Association Journal = Journal De l'Association Medicale Canadienne
Background: The Medical Outcomes Study 36-item Short Form (SF-36) is a widely used measure of health-related quality of life. Normative data are the key to determining whether a group or an individual...
Research Methodology > Outcome Measures > Health-Related Quality of LifeBone Health > Osteoporosis > Population-Based Screening Studies